Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Dose-escalated radiotherapy with PET/CT based treatment planning in combination with induction and concurrent chemotherapy in locally advanced (uT3/T4) squamous cell cancer of the esophagus: mature results of a phase I/II trial.
Pöttgen C, Gkika E, Stahl M, Abu Jawad J, Gauler T, Kasper S, Trarbach T, Herrmann K, Lehmann N, Jöckel KH, Lax H, Stuschke M. Pöttgen C, et al. Among authors: abu jawad j. Radiat Oncol. 2021 Mar 23;16(1):59. doi: 10.1186/s13014-021-01788-4. Radiat Oncol. 2021. PMID: 33757534 Free PMC article. Clinical Trial.
Hyperfractionated accelerated radiotherapy versus conventional fractionation both combined with chemotherapy in patients with locally advanced head and neck carcinomas: a retrospective analysis of a monoinstitutional series.
Welz H, Pöttgen C, Abu Jawad J, Wierlemann A, Wittig A, Stüben G, Budach V, Lehnerdt G, Jahnke K, Sack H, Stuschke M. Welz H, et al. Among authors: abu jawad j. Oncology. 2009;76(6):405-12. doi: 10.1159/000215927. Epub 2009 May 4. Oncology. 2009. PMID: 19407473
Accelerated hyperfractionated radiotherapy within trimodality therapy concepts for stage IIIA/B non-small cell lung cancer: Markedly higher rate of pathologic complete remissions than with conventional fractionation.
Pöttgen C, Eberhardt W, Graupner B, Theegarten D, Gauler T, Freitag L, Abu Jawad J, Wohlschlaeger J, Welter S, Stamatis G, Stuschke M. Pöttgen C, et al. Among authors: abu jawad j. Eur J Cancer. 2013 Jun;49(9):2107-15. doi: 10.1016/j.ejca.2013.02.030. Epub 2013 Mar 16. Eur J Cancer. 2013. PMID: 23510803
Helical tomotherapy for whole-brain irradiation with integrated boost to multiple brain metastases: evaluation of dose distribution characteristics and comparison with alternative techniques.
Levegrün S, Pöttgen C, Wittig A, Lübcke W, Abu Jawad J, Stuschke M. Levegrün S, et al. Among authors: abu jawad j. Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):734-42. doi: 10.1016/j.ijrobp.2013.03.031. Epub 2013 May 14. Int J Radiat Oncol Biol Phys. 2013. PMID: 23680034 Review.
Multi-scenario based robust intensity-modulated proton therapy (IMPT) plans can account for set-up errors more effectively in terms of normal tissue sparing than planning target volume (PTV) based intensity-modulated photon plans in the head and neck region.
Stuschke M, Kaiser A, Abu Jawad J, Pöttgen C, Levegrün S, Farr J. Stuschke M, et al. Among authors: abu jawad j. Radiat Oncol. 2013 Jun 18;8:145. doi: 10.1186/1748-717X-8-145. Radiat Oncol. 2013. PMID: 23773560 Free PMC article.
Spatial and dosimetric evaluation of residual distortions of prostate and seminal vesicle bed after image-guided definitive and postoperative radiotherapy of prostate cancer with endorectal balloon.
Levegrün S, Pöttgen C, Xydis K, Guberina M, Abu Jawad J, Stuschke M. Levegrün S, et al. Among authors: abu jawad j. J Appl Clin Med Phys. 2021 Jan;22(1):226-241. doi: 10.1002/acm2.13138. Epub 2020 Dec 30. J Appl Clin Med Phys. 2021. PMID: 33377614 Free PMC article.
SDF-1/CXCR4 expression is an independent negative prognostic biomarker in patients with head and neck cancer after primary radiochemotherapy.
De-Colle C, Menegakis A, Mönnich D, Welz S, Boeke S, Sipos B, Fend F, Mauz PS, Tinhofer I, Budach V, Abu Jawad J, Stuschke M, Balermpas P, Rödel C, Grosu AL, Abdollahi A, Debus J, Belka C, Ganswindt U, Pigorsch S, Combs SE, Lohaus F, Linge A, Krause M, Baumann M, Zips D; DKTK-ROG. De-Colle C, et al. Among authors: abu jawad j. Radiother Oncol. 2018 Jan;126(1):125-131. doi: 10.1016/j.radonc.2017.10.008. Epub 2017 Oct 20. Radiother Oncol. 2018. PMID: 29061496